跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 資昊
教授
,
醫學資訊研究所
合聘教授
,
醫務管理學系
合聘教授
,
醫學院人工智慧醫療碩士在職專班
合聘教授
,
醫學生物科技博士學位學程
成員
,
臺北醫學大學人工智慧醫療研究中心
https://orcid.org/0000-0001-7011-3754
電子郵件
kevinchang
tmu.edu
tw
h-index
3505
引文
30
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2003
2025
每年研究成果
概覽
指紋
網路
專案
(21)
研究成果
(122)
資料集
(44)
類似的個人檔案
(6)
指紋
查看啟用 Tzu-Hao Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
MicroRNA
93%
RNA
76%
Gene Expression
74%
Drug Resistance
51%
Messenger RNA
48%
Next Generation Sequencing
48%
RNA Sequence
43%
Support Vector Machine
39%
Gene Expression Profiling
39%
Biological Phenomena and Functions Concerning the Entire Organism
36%
Fibroblast
34%
Stem Cell
34%
Actin
32%
Catenin
32%
down Regulation
30%
Microarrays
29%
Carcinogenesis
27%
Cytoskeleton
27%
Clinical Decision Making
26%
Differential Gene Expression
26%
Binding Site
25%
Amino Acid Composition
25%
Promoter Region
24%
Riboswitch
24%
Protein-Protein Interaction
22%
Antimicrobial Peptides
22%
Ubiquitin
22%
Transcriptome
22%
Shear Stress
22%
Renin Angiotensin Aldosterone System
22%
Hemodialysis
22%
Collagen, Type XI, Alpha 1
22%
Polymerase Chain Reaction
21%
Phosphoinositide-Dependent Kinase-1
19%
Phosphotransferase
19%
Kinase
19%
Signal Transduction
19%
Artificial Neural Network
19%
Tumor Progression
19%
Comorbidity
19%
Clinical Research
19%
Epidermal Growth Factor Receptor
19%
Cancer Staging
18%
Quantitative Reverse Transcription Polymerase Chain Reaction
17%
Non-Coding RNA
17%
Lysine
17%
Metabolic Pathway
17%
Cell Maturation
17%
Lipid
17%
Medicine and Dentistry
Chronic Kidney Disease
69%
Cancer Cell
57%
Ovarian Cancer
57%
Malignant Neoplasm
50%
Mitral Insufficiency
45%
microRNA
45%
Krukenberg Tumor
41%
Biological Marker
39%
Cardiovascular System
38%
Hemodialysis
34%
Drug Resistance
31%
Neoplasm
27%
Cancer Growth
25%
Cohort Analysis
25%
Odds Ratio
24%
Left Atrium
23%
Catenin
22%
4 Iodo 2,5 Dimethoxyamphetamine
22%
Cancer Associated Fibroblast
22%
Dysbiosis
22%
Breast Cancer
22%
Inferior Vena Cava
22%
Disease
22%
Gene Expression
20%
Glomerular Filtration Rate
19%
Disease Exacerbation
19%
Clinical Research
18%
Apoplexy
18%
Collagen Type 11
17%
Metastatic Carcinoma
17%
Electronic Patient Record
17%
Atrial Fibrillation
16%
Tumor Progression
16%
Cardiovascular Disease
16%
Heart Failure
16%
Signal Transduction
15%
Retrospective Cohort Study
14%
Fibroblast
14%
Programmed Cell Death
14%
Drug Therapy
14%
Colon Cancer
13%
Overall Survival
13%
Electronic Health Record
13%
Rhinosinusitis
13%
Gene Expression Profiling
12%
Transcriptome
12%
Cancer Risk
12%
Cohort Study
12%
Kidney Function
12%
Gout
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
92%
Malignant Neoplasm
84%
Ovary Cancer
68%
Cohort Study
63%
microRNA
45%
Biological Marker
40%
Hemodialysis
34%
Drug Resistance
33%
Carcinogenesis
32%
Ovary Carcinoma
29%
Cancer Growth
24%
Acute Kidney Failure
23%
Endometrium Cancer
22%
Mitral Valve Regurgitation
22%
Clinical Research
22%
Cardiovascular Disease
21%
Comorbidity
20%
All Cause Mortality
19%
Collagen Type 11
17%
Tumor Growth
16%
Cisplatin
15%
Neoplasm
14%
Infection
13%
Colon Cancer
13%
Heart Failure
13%
Lymph Node Metastasis
13%
Atrial Fibrillation
12%
Gout
12%
SUMO 3 Protein
11%
Catenin
11%
Breast Cancer
11%
Targeted Drug Delivery
11%
Somatomedin Binding Protein 2
11%
Antiplatelet
11%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Metformin
11%
Endometrioid Carcinoma
11%
Membrane Receptor
11%
Mouth Cancer
11%
Lung Cancer
11%
Deterioration
11%
Benzodiazepine
11%
Cancer Survival
11%
Fracture
11%
Metabolic Syndrome X
11%
Brain Ischemia
11%
Allopurinol
11%
Creatinine
11%
DNA (Cytosine 5) Methyltransferase 1
11%
Transcriptome
11%